Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40

Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Healthcare Deal Volume Got a Jump Start in January

Healthcare Deal Volume Got a Jump Start in January

January was a fairly busy month for healthcare M&A. Preliminary data shows 133 deals reported, nearly equal to December’s 136. The momentum coming out of the fourth quarter spilled into the new year and even without a big boost in deal announcements from the J.P. Morgan Healthcare Conference, consolidation in the industry seems to be going full steam ahead. And yet. Compared with the 151 deals announced a year ago, M&A is off by 12%. Granted, we don’t see that many deals on a monthly basis, which makes for a hard comp here. But as we swing into February, deal flow has slowed noticably. It could be temporary, as investors take stock of the economic and political landscape and... Read More »
Health Care M&A Deals, Week Ending February 1, 2019

Health Care M&A Deals, Week Ending February 1, 2019

The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day, in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology     Acquirer Target Price Aldeyra Therapeutics, Inc. Helio Vision, Inc. $10,000,000 Neurocrine Biosciences, Inc. Rights to four gene therapy programs $165,000,000 Janssen Pharmaceuticals, Inc. Rights to retinal disease treatments $100,000,000 Tetra Bio-Pharma Panag... Read More »
Health Care M&A Deals, Week Ending February 1, 2019

Health Care M&A Deals, Week Ending January 25, 2019

The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day, in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm.   Behavioral Health Care Acquirer Target Price Beacon Specialized Living Services, Inc. Owakihi, Inc. N/A Biotechnology Acquirer Target Price BioNTech AG Operational antibody generation unit N/A Vertex Pharmaceuticals Incorporated License to two DNA-PK inhibitors N/A eHealth Acquirer... Read More »
Health Care M&A Deals, Week Ending February 1, 2019

Health Care M&A Deals, Week Ending January 18, 2019

The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day, in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm.   Behavioral Health Care Acquirer Target Price MEDIAN 2 addiction treatment clinics in Germany N/A Biotechnology Acquirer Target Price Apricus Biosciences, Inc. Seelos Therapeutics, Inc. N/A Celgene Corporation License to cell therapies N/A eHealth Acquirer Target Price PerfectServe... Read More »
Health Care M&A Deals, Week Ending February 1, 2019

Health Care M&A Deals, Week Ending January 11, 2019

The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day, in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology     Acquirer Target Price Eli Lilly and Company Loxo Oncology, Inc. $8,000,000,000 Knight Therapeutics Inc. Exclusive rights to commercialize Nerlynx $7,200,000 eHealth     Acquirer Target Price Medici Chiron Health N/A ZOLL Medical Corporation Payor... Read More »
Q4:18 Health Care Dollar Volume Was Just … Robust

Q4:18 Health Care Dollar Volume Was Just … Robust

Deal volume has climbed higher every year since 2012. Spending on those deals hasn’t been as predictable, which is why we watch deal volume more closely. But dollar signs attract attention, so here is where the preliminary results point. Combined spending in 2018 now stands at $330.3 billion and may rise slightly higher as we uncover more prices. The total is 21% higher than 2017’s $311.6 billion, but doesn’t come close to the $387.7 billion spent in 2014. That was the year Actavis plc (now NYSE: AGN) paid $66 billion for Allergan plc; Medtronic plc (NYSE: MDT) paid $42.9 billion for Covidien; and Actavis (then NYSE: ACT) acquired Forrest Laboratories for $25.0 billion. That year saw... Read More »